DIACOMIT® treatment should be undertaken under the supervision of a medical doctor who is knowledgeable about Dravet Syndrome. All initiation, change or modification of antiepileptic treatment must only be made with the approval of the medical practitioner who regularly follows the patient. If you should have any questions regarding treatments, you should feel free to ask this doctor.

DIACOMIT® is to be used as an add-on therapy to clobazam and valproate to treat generalised tonic-clonic seizures when these are not adequately controlled with clobazam and valproate.

In case of side effects, please contact the medical practitioner who regularly follows the patient. If required, he/she will adapt the doses of concomitant anti-epileptics treatments.